Devices descending from K961144
20 later devices reach MS-2000 through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K061961 | Art Lab Software | Pie Medical | 2006 | 18 | — |
| +1 | K011625 | Vasocor Vascular Diagnostic Center (Model 300) | Vasocor, Inc. | 2002 | 0 | — |
| +2 | K161359 | 6400 Ultrasound System,7400 Ultrasound System, 7410 Ultrasound System | Esaote, S.p.A. | 2016 | 4 | 5 |
| +2 | K153277 | 6200 Ultrasound System and 6250 Ultrasound System | Esaote, S.p.A. | 2016 | 12 | — |
| +3 | K191072 | 7410 Ultrasound System (MyLabSigma) | Esaote, S.p.A. | 2019 | 0 | — |
| +3 | K190989 | 6400 Ultrasound System (MyLabX6, MyLabX7) | Esaote, S.p.A. | 2019 | 0 | — |
| +3 | K190447 | 7400 Ultrasound Systems | Navigant Consulting - on Behalf of Esaote S.P.A. | 2019 | 0 | — |
| +3 | K163119 | NaviSuite SSI Edition | Medcom GmbH | 2017 | 1 | — |
| +3 | K163082 | 6200 Ultrasound System and 6250 Ultrasound System | Esaote, S.p.A. | 2017 | 9 | 2 |
| +3 | K162290 | MyLabSix CrystaLine | Esaote, S.p.A. | 2016 | 0 | — |
| +4 | K173291 | 6440 Ultrasound System | Esaote, S.p.A. | 2018 | 8 | — |
| +4 | K170841 | BiopSee, Mobile US | Medcom GmbH | 2017 | 0 | — |
| +5 | K230179 | 6440 MyLabX90 | Esaote, S.p.A. | 2023 | 4 | 1 |
| +5 | K192157 | 6450 Ultrasound system | Esaote, S.p.A. | 2019 | 4 | — |
| +5 | K183191 | 6420 Ultrasound System | Esaote, S.p.A. | 2018 | 0 | — |
| +6 | K243253 | 6600 Ultrasound System (MyLabA50); 6600 Ultrasound System (MyLabA70) | Esaote, S.p.A. | 2025 | 2 | — |
| +6 | K241671 | 6450 Ultrasound System (MyLabE80); 6450 Ultrasound System (MyLabE85) | Esaote, S.p.A. | 2025 | 2 | — |
| +6 | K212021 | 6430 MyLabX75, 6430 MyLab XPro75 | Esaote, S.p.A. | 2021 | 0 | — |
| +7 | K253288 | 6450 Ultrasound System (MyLabE80); 6450 Ultrasound System (MyLabE85) | Esaote, S.p.A. | 2026 | 0 | — |
| +7 | K253310 | 7600 Ultrasound System (MyLabC25); 7600 Ultrasound System (MyLabC30) | Esaote, S.p.A. | 2025 | 0 | — |